New melanoma vaccine could cut risk of cancer recurrence

Melanoma study finds mRNA vaccine combined with standard treatment could reduce recurrenceSee more

New vaccine could reduce melanoma recurrenceSee more

Ground-breaking vaccine preventing melanoma | 7NEWSSee more

Melanoma vaccine trial appears to reduce skin cancer recurrenceSee more

Experimental melanoma vaccine achieves remarkable results in Australian trial | 7NEWSSee more

New cancer vaccine boosts survival rate, Moderna saysSee more

Cancer vaccines in development, Dr, Kohli explainsSee more

New study finds mRNA vaccine helps battle against melanomaSee more

Thousands of cancer patients to trial personalised vaccines in England | BBC NewsSee more

Merck-Moderna Vaccine Cuts Risk of Skin Cancer ReturningSee more

Cancer Vaccine: Moderna and Merck's Melanoma vaccine moves on to third trial phaseSee more

Experimental vaccine helps delay return of serious skin cancer, researchers saySee more

Moderna CEO talks skin cancer vaccine: It's a big deal for melanoma patientsSee more

Dr. Meredith McKean on mRNA Combined Immunotherapy for Melanoma – NBCLXSee more

Merck-Moderna Vaccine Helps Keep Patients Free from Skin CancerSee more

Moderna, Merck Skin Cancer Vaccine Cuts Risks of Death in TrialSee more

Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrenceSee more

Cancer Vaccine Trials—Using Same mRNA Tech Behind Covid Shots—Could Launch In U.K. This SeptemberSee more

Melanoma mRNA vaccine may improve life span of patientsSee more